Patents Assigned to BIOPOLIS, S.L.
  • Strain of subsp. lactis CECT 8145 and use thereof for the treatment and/or prevention of excess weight and obesity and associated diseases
    Patent number: 10946051
    Abstract: The invention is applicable within the food and pharmaceutical industry. More specifically, it relates to a novel strain of the species Bifidobacterium animalis subsp. lactis CECT 8145, the cell components, metabolites and secreted molecules thereof, which, incorporated into food and/or pharmaceutical formulations, can be used in the treatment and/or prevention of excess weight and obesity and related diseases such as metabolic syndrome, hypertension, glycemia, inflammation, type 2 diabetes, cardiovascular diseases, hypercholesterolemia, hormonal alterations, infertility, etc.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: March 16, 2021
    Assignee: BIOPOLIS, S.L.
    Inventors: Patricia Martorell Guerola, Mª Empar Chenoll Cuadros, Daniel Ramón Vidal, Pepa Ortiz Serrano, Silvia Llopis Pla, Núria Gonzalez Martínez, Salvador Genovés Martínez, Beatriz Casinos Ramo, Ángela Silva Angulo, Amaya Aleixandre
  • Use of probiotics in the treatment and/or prevention of psoriasis
    Patent number: 10912802
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus rhamnosus, in particular the strains B. lactis CECT 8145, B. longum ES1 CECT 7347 and/or L. rhamnosus CECT 8361, in the treatment and/or prevention of psoriasis outbreaks or psoriasis.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: February 9, 2021
    Assignees: Bionou Research, S.L., KOROTT, S.L., BIOPOLIS, S.L.
    Inventors: Vicente Manuel Navarro López, Ana Adela Ramírez Boscá, José Manuel Pérez Orquín, Daniel Ramón Vidal, Salvador Genovés Martínez, María Empar Chenoll Cuadros, Francisco Manuel Codoñer Cortés
  • Lactobacillus Rhamnosus Strain for Reducing Body Fat Accumulation
    Publication number: 20150283186
    Abstract: The invention relates to the use of Lactobacillus rhamnosus strain CNCM 1-3690 for reducing body fat accumulation and treating disorders resulting therefrom, such as overweight, obesity, and obesity-related disorders.
    Type: Application
    Filed: November 12, 2012
    Publication date: October 8, 2015
    Applicants: COMPAGNIE GERVAIS DANONE, BIOPOLIS, S.L.
    Inventors: Gianfranco Grompone, Daniel Ramon Vidal, Patricia Martorell Guerola, Salvador Genoves Martinez, Pepa Ortiz Soriano, Silvia Llopis Pla, Nuria Gonzalez Martinez
  • METHOD FOR PRODUCING 2,3-BUTANEDIOL USING IMPROVED STRAINS OF RAOULTELLA PLANTICOLA
    Publication number: 20150191752
    Abstract: The invention relates to a method for producing 2,3-butanediol using improved strains of Raoultella planticola, and to novel mutant strains obtained by random mutagenesis from the bacterial species Raoultella planticola CECT843, that can be used in the industrial production of 2,3-butanediol from glycerol. The invention preferably relates to the Raoultella planticola strains designated IA1 and IIIA3 and deposited in the Spanish Type Culture Collection (CECT) under deposit number CECT8158 (corresponding to the strain designated IA1) and deposit number CECT8159 (corresponding to the strain designated IIIA3). The invention also relates to a method for producing 2,3-butanediol from glycerol by means of a biotechnological process using the novel strains of the invention.
    Type: Application
    Filed: July 22, 2013
    Publication date: July 9, 2015
    Applicants: UNIVERSIDAD COMPLUTENSE DE MADRID, BIOPOLIS, S.L.
    Inventors: Antonia Maria Rojas Martinez, Silvia Segarra Manzano, Alejandro Montesinos Paes, Marta Tortajada Serra, Daniel Ramon Vidal, Victoria Eugenia Santos Mazorra, Miguel Ladero Galan, Felix Garcia-Ochoa Soria, Vanessa Ripoll Morales
  • OBTAINMENT OF BIOACTIVE PRODUCTS FROM COCOA HAVING INHIBITORY ACTIVITY AGAINST THE PEP ENZYME AND ANTIOXIDANT AND/OR ANTINEURODEGENERATIVE ACTIVITY
    Publication number: 20130035291
    Abstract: The present invention relates to the production of bioactive products from raw plant matter, namely cocoa extracts. The said products have one or more biopeptides with prolyl endopeptidase (PEP) enzyme inhibitory activity in vitro and/or antioxidant and/or antineurodegenerative capacity in vivo and can be used in dietetics and in the food and pharmaceutical industries.
    Type: Application
    Filed: December 23, 2009
    Publication date: February 7, 2013
    Applicants: NATRACEUTICAL INDUSTRIAL S.L.U., BIOPOLIS, S.L.
    Inventors: Esther Bataller Leiva, Salvador Genoves Martinez, Patricia Martorell Guerola, Daniel Ramon Vidal, Aida Ibañnez Lopez, Silvia Llopis Pla, Nuria Gonzalez Martinez, Honorato Monzo Oltra, Begoña Muguerza Marquinez
  • OBTAINING COCOA EXTRACTS RICH IN BIOACTIVE PEPTIDES WITH ACE AND PEP ENZYME INHIBITORY ACTIVITY
    Publication number: 20110213122
    Abstract: The present invention relates to obtaining bioactive peptides from plant raw materials, specifically cocoa extracts, by means of enzyme treatment. Said biopeptides have angiotensin converting enzyme (ACE) and prolyl endopeptidase enzyme (PEP) inhibitory activity in vitro and/or antioxidant activity in vivo, being able to be used in the food, dietetic and pharmaceutical industry.
    Type: Application
    Filed: August 1, 2008
    Publication date: September 1, 2011
    Applicants: NATRACEUTICAL, S.A., BIOPOLIS, S.L.
    Inventors: Begona Muguerza Marquinez, Honorato Monzo Oltra, Natalia Alepuz Rico, Esther Bataller Leiva, Salvador Genoves Martínez, Maria Enrique López, Patricia Martorell Guerola, Daniel Ramon Vidal